levodopa/carbidopa/entacapone orion
orion corporation - l-dopa, карбидопа, энтакапон - Паркинсонова болест - Нервна система - Леводопа/carbidopa/entacapone Орион е показан за лечение на възрастни пациенти с болестта на Паркинсон и край на доза моторни колебания не стабилизирани на леводопа / допа-декарбоксилаза (ddc)-инхибитор лечение.
lapozan 5 mg film - coated tablets
medochemie ltd., - Оланзапин - 5 mg film - coated tablets
lapozan 10 mg film - coated tablets
medochemie ltd., - Оланзапин - 10 mg film - coated tablets
lapozan 5 mg orodispersible tablets
medochemie ltd., - Оланзапин - 5 mg orodispersible tablets
lapozan 10 mg orodispersible tablets
medochemie ltd. - Оланзапин - 10 mg orodispersible tablets
apo - infect spag. peka
pekana-naturheilmittel gmbh -
apo - go pen 10 mg/ml solution for injection
britannia pharmaceuticals limited - 10 mg/ml solution for injection
apo - go ampoules 10 mg/ml solution for injection or infusion
britannia pharmaceuticals limited - 10 mg/ml solution for injection or infusion
apo - go pfs 5 mg/ml solution for infusion in pre - filled syringe
britannia pharmaceuticals limited - 5 mg/ml solution for infusion in pre - filled syringe
zolsketil pegylated liposomal
accord healthcare s.l.u. - doxorubicin hydrochloride, liposomal - ovarian neoplasms; sarcoma, kaposi; multiple myeloma - doxorubicin - zolsketil pegylated liposomal is a medicine used to treat the following types of cancer in adults:• breast cancer that has spread to other parts of the body in patients at risk of heart problems. zolsketil pegylated liposomal is used on its own for this disease;• advanced ovarian cancer in women whose previous treatment including a platinum-based cancer medicine has stopped working;• multiple myeloma (a cancer of the white blood cells in the bone marrow), in patients with progressive disease who have received at least one other treatment in the past and have already had, or are unsuitable for, a bone marrow transplantation. zolsketil pegylated liposomal is used in combination with bortezomib (another cancer medicine);• kaposi’s sarcoma in patients with aids who have a very damaged immune system. kaposi’s sarcoma is a cancer that causes abnormal tissue to grow under the skin, on moist body surfaces or on internal organs. zolsketil pegylated liposomal contains the active substance doxorubicin and is a ‘hybrid medicine’. this means that it is similar to a ‘reference medicine’ containing the same active substance called adriamycin. however, in zolsketil pegylated liposomal the active substance is enclosed in tiny fatty spheres called liposomes, whereas this is not the case for adriamycin.